19-42547219-A-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000594624.8(LIPE-AS1):​n.233+61996A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.475 in 151,646 control chromosomes in the GnomAD database, including 20,728 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.48 ( 20728 hom., cov: 29)

Consequence

LIPE-AS1
ENST00000594624.8 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.96

Publications

0 publications found
Variant links:
Genes affected
LIPE-AS1 (HGNC:48589): (LIPE antisense RNA 1)
CEACAM1 (HGNC:1814): (CEA cell adhesion molecule 1) This gene encodes a member of the carcinoembryonic antigen (CEA) gene family, which belongs to the immunoglobulin superfamily. Two subgroups of the CEA family, the CEA cell adhesion molecules and the pregnancy-specific glycoproteins, are located within a 1.2 Mb cluster on the long arm of chromosome 19. Eleven pseudogenes of the CEA cell adhesion molecule subgroup are also found in the cluster. The encoded protein was originally described in bile ducts of liver as biliary glycoprotein. Subsequently, it was found to be a cell-cell adhesion molecule detected on leukocytes, epithelia, and endothelia. The encoded protein mediates cell adhesion via homophilic as well as heterophilic binding to other proteins of the subgroup. Multiple cellular activities have been attributed to the encoded protein, including roles in the differentiation and arrangement of tissue three-dimensional structure, angiogenesis, apoptosis, tumor suppression, metastasis, and the modulation of innate and adaptive immune responses. Multiple transcript variants encoding different isoforms have been reported, but the full-length nature of all variants has not been defined. [provided by RefSeq, May 2010]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000594624.8, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.814 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000594624.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LIPE-AS1
NR_073179.1
n.1451-103868A>T
intron
N/A
LIPE-AS1
NR_073180.1
n.205+61996A>T
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LIPE-AS1
ENST00000594624.8
TSL:1
n.233+61996A>T
intron
N/A
CEACAM1
ENST00000600172.1
TSL:5
c.-101+13979T>A
intron
N/AENSP00000471566.1M0R109
LIPE-AS1
ENST00000594688.1
TSL:2
n.1451-103868A>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.475
AC:
71933
AN:
151524
Hom.:
20672
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.821
Gnomad AMI
AF:
0.213
Gnomad AMR
AF:
0.396
Gnomad ASJ
AF:
0.352
Gnomad EAS
AF:
0.150
Gnomad SAS
AF:
0.324
Gnomad FIN
AF:
0.380
Gnomad MID
AF:
0.377
Gnomad NFE
AF:
0.343
Gnomad OTH
AF:
0.431
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.475
AC:
72049
AN:
151646
Hom.:
20728
Cov.:
29
AF XY:
0.469
AC XY:
34729
AN XY:
74064
show subpopulations
African (AFR)
AF:
0.822
AC:
33931
AN:
41294
American (AMR)
AF:
0.396
AC:
6044
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.352
AC:
1223
AN:
3470
East Asian (EAS)
AF:
0.151
AC:
774
AN:
5140
South Asian (SAS)
AF:
0.323
AC:
1544
AN:
4782
European-Finnish (FIN)
AF:
0.380
AC:
4000
AN:
10516
Middle Eastern (MID)
AF:
0.395
AC:
116
AN:
294
European-Non Finnish (NFE)
AF:
0.343
AC:
23311
AN:
67878
Other (OTH)
AF:
0.433
AC:
913
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1523
3046
4570
6093
7616
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
596
1192
1788
2384
2980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.420
Hom.:
1857
Bravo
AF:
0.490
Asia WGS
AF:
0.316
AC:
1098
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.39
DANN
Benign
0.69
PhyloP100
-2.0

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10401935;
hg19: chr19-43051371;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.